NOVEMBER 2023LIFE SCIENCES REVIEW6CXO INSIGHTSUnlocking The Potential of Next-Generation SequencingPeter René Hesse,Vice President Head of Genomics Business, QIAGEN19New Product Liability Directive in Europe: Implications for the Pharmaceutical IndustryXavier Salas,Corporate Legal & Compliance Manager,Neuraxpharm2616STATE OF THE INDUSTRYSanger Sequencing Powering Europe's Genomics Revolution
< Page 5 | Page 7 >